Advanced in Granulomatous Hypophysitis

Vincent Rohmer

4, Rue Larrey, 
Angers, FR 
Advanced in Granulomatous Hypophysitis
4, Rue Larrey, 
Angers, FR 
OverviewLocationsClinical Research

Overview

Vincent Rohmer practices in Angers, France. Mr. Rohmer is rated as an Advanced expert by MediFind in the treatment of Granulomatous Hypophysitis. His top areas of expertise are Multiple Endocrine Neoplasia, Multiple Endocrine Neoplasia Type 2, Medullary Thyroid Carcinoma, Thyroidectomy, and Appendectomy.

His clinical research consists of co-authoring 43 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Granulomatous Hypophysitis.

Gender
Male

Locations

4, Rue Larrey, Angers, 49100, France
Other Locations
Nantes, France
4 Rue Larrey 49100 Angers, Larrey, 49100, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Pharmacokinetic and Imaging Optimization Study of Pretargeted Immuno-PET Using the Anti-CEA x Anti-HSG TF2 Bispecific Antibody and 68Ga-IMP-288 Peptide in Patients With Recurrences of Medullary Thyroid Carcinoma.
Pharmacokinetic and Imaging Optimization Study of Pretargeted Immuno-PET Using the Anti-CEA x Anti-HSG TF2 Bispecific Antibody and 68Ga-IMP-288 Peptide in Patients With Recurrences of Medullary Thyroid Carcinoma.
Enrollment Status: Completed
Publish Date: July 26, 2022
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Randomized, Multicenter, Open-label, Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
A Randomized, Multicenter, Open-label, Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
Enrollment Status: Completed
Publish Date: August 16, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

43 Total Publications

NATURAL HISTORY OF MEDULLARY THYROID CARCINOMA IN MEN-2 PATIENTS CARRYING A VARIANT AT CODON 804 IN THE RET PROTO-ONCOGENE: A STUDY BY THE FRENCH NEUROENDOCRINE TUMOR GROUP (GTE).
NATURAL HISTORY OF MEDULLARY THYROID CARCINOMA IN MEN-2 PATIENTS CARRYING A VARIANT AT CODON 804 IN THE RET PROTO-ONCOGENE: A STUDY BY THE FRENCH NEUROENDOCRINE TUMOR GROUP (GTE).
Journal: Annales d'endocrinologie
Published: September 06, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rohmer's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 20 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile